Revenue | ₹1,205.50Cr |
Net Profits | ₹82.19Cr |
Net Profit Margins | 6.82% |
Strides Pharma Science Ltd’s revenue jumped 17.04% since last year same period to ₹1,205.50Cr in the Q4 2024-2025. On a quarterly growth basis, Strides Pharma Science Ltd has generated 3.9% jump in its revenue since last 3-months.
Strides Pharma Science Ltd’s net profit jumped 352.09% since last year same period to ₹82.19Cr in the Q4 2024-2025. On a quarterly growth basis, Strides Pharma Science Ltd has generated -6.55% fall in its net profits since last 3-months.
Strides Pharma Science Ltd’s net profit margin jumped 286.26% since last year same period to 6.82% in the Q4 2024-2025. On a quarterly growth basis, Strides Pharma Science Ltd has generated -10.06% fall in its net profit margins since last 3-months.
The revenue for Strides Pharma Science Ltd in the Q4 results 2024 was ₹1,205.50Cr.
The net profit for Strides Pharma Science Ltd in the Q4 results 2024 was ₹82.19Cr.
The net profit margin for Strides Pharma Science Ltd in the Q4 results 2024 was 6.82%.
The revenue for Strides Pharma Science Ltd in the Q4 results 2023 was ₹1,029.96Cr.
The net profit for Strides Pharma Science Ltd in the Q4 results 2023 was ₹18.18Cr.
The net profit margin for Strides Pharma Science Ltd in the Q4 results 2023 was 1.77%.